Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Omnicare purchases rival company NeighborCare
The definitive merger agreement was unanimously approved by the directors of both companies. Omnicare agreed to pay $1.55 billion to secure the deal that will result in the
The definitive merger agreement was unanimously approved by the directors of both companies. Omnicare agreed to pay $1.55 billion to secure the deal that will result in the
Based on research showing that Ceragenix’s drugs have activity similar to human angiostatins, two of the company’s lead cationic steroid antibiotic (CSA) compounds have been accepted by the
The compound, PTC124, has been granted orphan drug status by the Committee for Orphan Medicinal Products, a unit of the European Medicines Agency (EMEA). Such status is granted
Human Genome is developing LymphoStat-B as a potential treatment for rheumatoid arthritis and systemic lupus erythematosus, already establishing the drug’s safety and efficacy during initial clinical trials. LymphoStat-B
Under the terms of the agreement, Napo has granted development and commercialization rights to Glenmark in their territories for pediatric diarrhea, acute infectious diarrhea and AIDS-related diarrhea. Glenmark
The issued patent covers a novel class of potent apoptosis inducers with vascular targeting activity that inhibit microtubule formation. The lead compound in this series is MX2407, which
The pivotal trial is a placebo-controlled morbidity and mortality study with over 2,000 patients, designed to assess time to doubling of serum creatinine, end-stage renal disease or death
Schering-Plough is planning to use ViroLogic’s HIV resistance testing technology in the development of its CCR5 receptor antagonist, vicriviroc. CCR5 receptor antagonists are a type of HIV Entry
Tarceva is an oral tablet indicated for daily administration in the treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least
According to the company, NanoEmulsion acts as a vehicle for lipophilic drugs directly to the tissue. Preclinical data has revealed positive effects of the technology when applied to